Oxidative stress and inflammatory biomarkers appear to be promising diagnostic and prognostic tools in patients with heart failure.
Systematic Review
Do oxidative stress and inflammatory biomarkers have diagnostic and prognostic value in patients with heart failure?
Oxidative stress and inflammatory biomarkers may serve as promising diagnostic and prognostic tools in heart failure, complementing standard natriuretic peptides.
Heart failure (HF) remains a major medical and social problem. The NT-pro-brain natriuretic peptide (NT-proBNP) and its active form, brain-type natriuretic peptide (BNP), in a simple blood test are the gold-standard biomarkers for HF diagnosis. However, even good biomarkers such as natriuretic peptides fail to predict all the risks associated with HF due to the diversity of the mechanisms involved. The pathophysiology of HF is determined by numerous factors, including oxidative stress, inflammation, neuroendocrine activation, pathological angiogenesis, changes in apoptotic pathways, fibrosis and vascular remodeling. High readmission and mortality rates prompt a search for new markers for the diagnosis, prognosis and treatment of HF. Oxidative-stress-mediated inflammation plays a crucial role in the development of subsequent changes in the failing heart and provides a new insight into this complex mechanism. Oxidative stress and inflammatory biomarkers appear to be a promising diagnostic and prognostic tool in patients with HF. This systematic review provides an overview of the current knowledge about oxidative stress and inflammation parameters as markers of HF.
Wróbel-Nowicka et al. (Thu,) conducted a systematic review in Heart failure. Oxidative stress and inflammatory biomarkers was evaluated. Oxidative stress and inflammatory biomarkers appear to be promising diagnostic and prognostic tools in patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: